Likewise and confirming the Th1-like immune activation pattern in tumour-adjacent patient samples, MHC I gene expression, cytolytic activity and type I and II interferon response all were strongly augmented (Fig. 2A, HCC-NT vs. HL). Here, SGCG is linked to hepatocellular carcinoma.